Helicobacter pylori

A Gram-negative bacterium that colonizes the stomach and is associated with gastritis, ulcers, and gastric cancer.

Pathogen Proteobacteria Gastritis, Peptic Ulcers

Classification


Kingdom
Bacteria
Phylum
Proteobacteria
Class
Epsilonproteobacteria
Order
Campylobacterales
Family
Helicobacteraceae
Genus
Helicobacter
Species
Helicobacter pylori

Morphology


Shape
Helical (spiral-shaped)
Size
~2.5-5.0 μm in length, ~0.5-1.0 μm in diameter
Gram Stain
Gram-negative
Arrangement
Single or paired
Motility
Motile (flagella-mediated)
Special Features
Produces urease to neutralize stomach acid, has multiple flagella for motility

Habitat & Distribution


Natural Habitat
Human stomach
Geographic Distribution
Worldwide
Human Association
Pathogenic in certain conditions
Transmission
Oral-oral, fecal-oral routes

Pathogenesis & Clinical Significance

Helicobacter pylori is a major bacterial pathogen associated with gastric ulcers, gastritis, and an increased risk of gastric cancer.

  • Virulence Factors: Urease, VacA toxin, CagA protein, flagella
  • Associated Diseases: Peptic ulcers, chronic gastritis, gastric cancer
  • Clinical Symptoms: Abdominal pain, nausea, bloating, loss of appetite, vomiting
  • High-Risk Groups: Individuals with poor sanitation, those in developing countries, people with a family history of gastric cancer

Its persistence in the gastric mucosa and its role in severe gastrointestinal diseases make it a critical target for eradication strategies.

The diagnosis of Helicobacter pylori infection relies on various laboratory and non-invasive tests.

Diagnostic Methods
  • Urea Breath Test: Detects urease activity in the stomach
  • Stool Antigen Test:: Identifies H. pylori antigens in stool samples
  • Endoscopy with Biopsy: Histological examination and rapid urease test
  • Serology: Detects antibodies against H. pylori (less commonly used)
Treatment Approaches
  • First-line Treatments: Triple therapy (proton pump inhibitor, clarithromycin, amoxicillin or metronidazole)
  • Alternative Therapies: Quadruple therapy (bismuth, proton pump inhibitor, metronidazole, tetracycline)
  • Antimicrobial Resistance: Rising resistance to clarithromycin and metronidazole
  • Supportive Care: Dietary modifications, symptom management, probiotics

Prevention & Public Health Considerations

Prevention Strategies


  • Proper hygiene, including handwashing and food safety practices
  • Safe drinking water and proper sanitation
  • Responsible antibiotic use to prevent resistance

Preventing Helicobacter pylori infections relies on improving sanitation, promoting good hygiene, and limiting transmission through contaminated food and water.

Global Impact


Helicobacter pyloriinfection is highly prevalent worldwide, particularly in low-income regions where sanitation is inadequate.

>50%

Approximately half of the world's population is infected with H. pylori, though many remain asymptomatic.

While the infection is declining in developed nations, it remains a significant burden in developing countries due to poor sanitation and lack of access to healthcare.

References